Article Text

T-cell prolymphocytic leukaemia (T-PLL): a rare disease with a grave prognosis
  1. Abhirami Vivekanandarajah,
  2. Jean Paul Atallah,
  3. Shilpi Gupta
  1. Department of Hematology/Oncology, Staten Island University Hospital, Staten Island, New York, USA
  1. Correspondence to Dr Abhirami Vivekanandarajah, avivek27{at}


T-cell prolymphocytic leukaemia (T-PLL) is an extremely uncommon haematological malignancy that has an aggressive course and a grave prognosis. We describe a patient who presented with lymphocytosis, scalp erythema, ascites and splenomegaly and was diagnosed with T-PLL. He was treated with alemtuzumab with a good response and was referred for allogeneic stem cell transplantation.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.